Articles Posted in Zantac

This page predicts Zantac lawsuit settlement amounts.  Our attorneys also provide the latest updates from the Zantac class action lawsuit as of August 11, 2022.

Projecting Zantac Settlement Amounts

It is impossible to know what the average compensation payout might be in the Zantac litigation at this stage. But projecting settlement amounts from this acid reflux drug is what stock analysts and shareholders for Sanofi-Aventis, Boehringer Ingelheim, Pfizer, and GlaxoSmithKline are doing –  and baking those future projected settlements and verdicts into the defendants’ stock prices.

The Zantac cancer lawsuits are heating up.  Discovery is moving forward surprisingly quickly given the pandemic. The first Zantac class action trial will be in October 2022.

Plaintiffs’ Zantac lawyers – like our law firm – are making one last push for new Zantac plaintiffs.  Our lawyers have signed up hundreds of plaintiffs for Zantac cancer lawsuits.

If you have cancer and were taking Zantac, don’t delay.  There is a statute of limitations for a Zantac lawsuit that creates a deadline to sue. (That deadline may have passed for a minority of victims.)  Call us today at 800-553-8082 or get a free online claim evaluation.

Bladder cancer has recently become the focus of the ongoing Zantac lawsuit. In this post, we will look at bladder cancer in personal injury lawsuits.

We examine the nature of bladder cancer as a disease and as an injury in medical malpractice, product liability, and other types of tort cases. Our lawyers also discuss the settlement compensation amounts for bladder cancer in tort cases.

Bladder cancer has become a focus of the Zantac lawsuit because the science linking bladder cancer and NDMA is probably stronger for Zantac than any other cancer.  These may be the strongest of the five cancers that are being pursued in the Zantac class action lawsuit. So there is a new focus on Zantac bladder cancer lawsuits than we saw earlier in the litigation.

The last two years have been pretty bad for the popular heartburn drug Zantac after testing revealed that it contained significantly high levels of the carcinogen N-Nitrosodimethylamine (NDMA). This led to Zantac being pulled off the shelves of major retailers and eventually a nationwide FDA recall.

Hundreds of individuals have now filed lawsuits against Zantac’s manufacturers. The suits alleged that taking Zantac caused the plaintiffs to develop certain types of cancer. Hundreds more Zantac cancer lawsuits are expected to be filed/tolled in the MDL (which really means the claims are “kinda filed” without all of the formalities).

Contact Information